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Introduction: The development of isolation strategies to prevent the spread of COVID -19 could affect the lives of 
Haemophilia patients beyond the risk of infection. In order to prevent this, the Haemophilia Treatment Centre, 
Rawalpindi, adopted additional combat strategies including the use of telephonic and video consultations, 
dispensing medicine at home and single-day treatments. 
Objective: To assess the impact of the COVID-19 pandemic and associated lockdown and changes in Standard 
Operating Procedures (SOPs) on the working of Haemophilia Treatment Centre, Rawalpindi and on the lives of 
its registered patients. 
Materials and Methods: An observational study was carried out at the Haemophilia Treatment Centre, 
Rawalpindi, between September 2019 and August 2020. 
Results. Among patients on Low Dose Prophylaxis (LDP) regimen, no difference in musculoskeletal health, 
bleeding episodes, inhibitor status, psychosocial health and nutritional status was observed among the two time 
periods. None of the staff members or patients was affected by the COVID-19. 
Conclusion: Our study shows that timely anticipation of the potential impact of a pandemic and prompt 
development of modified mechanisms can indeed make the working of a Health Care Centre successful and 
prevent side effects on the lives of its patients. 
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Introduction 
 
Haemophilia is one of the most common congenital 
bleeding disorders,1 with the majority of patients 
having haemophilia A (80-85%).2 Patients have a 
bleeding tendency, the severity of which correlates 
with clotting factor levels.2 Regular infusion of factor 
concentrates to prevent bleeding in haemophilia is the 
treatment of choice.2 However, the standard dose 
prophylaxis is very expensive, therefore, a low dose 
prophylaxis (LDP) project is currently underway at the 
Haemophilia Treatment Centre (HTC), Rawalpindi 
where 14 haemophilia A patients are currently on an 
LDP regime of 250 IU of factor concentrates once 
weekly. 
The Corona Virus Disease 2019 (COVID-19) is a global 
crisis that has affected the lives of people around the 
world. To limit the spread of COVID-19, governments 
have been obliged to adopt isolation strategies ranging 
from social distancing to imposing lockdown measures 
in some areas. Healthcare centres are required to 
follow strict Standard Operating Procedures (SOPs) 
that include vigilant disinfection and social 
distancing.3 
The HTC, Rawalpindi anticipated that such 
confinement may result in the lack of access to 
healthcare and medication and may also harm the 
psychosocial and physical health of its patients, 
including the 14 patients who were currently enrolled 
in the LDP trial.  To prevent this, HTC encouraged 
haemophilia patients to use the services of telephone 
and video consultations. They were offered at-home 
dispensing of medicines. They were motivated to use 
alternative mechanisms to stay in touch with family 
and friends and modify physical activities that can be 
performed at home. 
The purpose of this study was to assess whether HTC, 
Rawalpindi was successful in safely supporting all 
haemophilia patients during the pandemic, measured 
by assessing outcomes before and during the 
pandemic on the 14 patients enrolled in the LDP trial. 
 
Materials and Methods 
 
An observational study was carried out at the HTC, 
Rawalpindi from September 1, 2019, to August 31, 
2020, to assess the effect of the implementation of 
COVID-19 guidelines. This timeline was divided into 
two periods: 
 Pre-Pandemic (September 1, 2019 - February 
29, 2020). 
 Intra-Pandemic (March 1, 2020 - August 31, 
2020) 
The pre-pandemic period is defined as the 6 months 
before the arrival of COVID -19 in Pakistan. The intra-
pandemic period is defined as the 6 months following 
the start of COVID-19 in Pakistan, including the 
introduction of strict SOPs to restrict the further 
spread of the disease. 
As part of the LDP trial, patients were required to 
come to the HTC, Rawalpindi every week for Factor 
VIII infusions. The patient was assessed physically 
with a manual check-up of Joints, history of any bleed 
whether Spontaneous or Traumatic, limitations in 
activities and psychosocial integration  
At the start of the pandemic in Pakistan, the HTC, 
Rawalpindi developed SOPs for staff based on 
recommendations by the World Federation of 
Haemophilia (WFH) and the World Health 
Organisation (WHO).3,4,5,6 These included regular 
handwashing, use of sanitisers, masks, gloves and 
overalls for all staff. Regular disinfection of frequently 
touched areas and social distancing was enforced. 
Only one attendant per patient was allowed and the 
children play area was closed.  All HTC related events 
were delayed and all elective and non-urgent surgeries 
and procedures were postponed.  The HTC remained 
open throughout the pandemic and patients were 
timely given life-saving treatments. Virtual and 
telephonic visits were conducted when possible.  
To assess if patients were supported during the 
pandemic, we compared patient outcomes during the 
pre-pandemic period to the intra-pandemic period on 
the 14 patients on the LDP trial. Patient and treatment 
compliance & clinical outcomes were assessed. Patient 
compliance was assessed by the regularity of patients 
visits, both virtual & physical. Treatment compliance 
was assessed by their use of FVIII concentrates. The 
clinical outcomes of total bleeding events, hospital 
admissions, emergency HTC visits, inhibitor status, 
musculoskeletal health and psychosocial health were 
also compared between the two time periods. 
Musculoskeletal health was assessed using HJHS  and 
psychosocial health was assess by a proforma which 
measured the general sense of well-being, self-esteem 
& confidence of the  family and the independence & 
interactions of the patient with other family members 
& a shift in treatment-related pain & fear of  injections.  
All patients were advised to inform both the HTC and 
the hospital in the case were infected with the COVID-
19 so the treating physician would not misinterpret the 
coagulation status of the patient. 
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Data were obtained retrospectively from written 
medical records for the pre-pandemic period and 




All SOPs for preventing the spread of COVID-19 were 
strictly followed by the staff, patients and their 
attendants. Throughout the pandemic, patients were 
provided timely life-saving treatments. All staff 
members continued working throughout the intra-
pandemic period. During this period, only two staff 
members developed fever, sore throat and body aches. 
They were advised to stay home and get COVID-19 
testing done, both of which were negative. 
A total of 1483 and 1562 in-person visits occurred 
during the pre and intra-pandemic periods, 
respectively (Table 1). There was a small increase in 
virtual visits and a marked increase in telephonic 
communication.  
Table 1: Comparison of HTC and Patient Visits 







Patient Visits, N 1483 1562 
Virtual Visits, N 9 15 
Telecommunication, N 60 116 




Factor VIII Administered, IU 1375950 1200530 
 
Among the 14 patients on LDP, treatment compliance 
was 100% (Table 2). None of the patients developed an 
inhibitor, only one was referred to the orthopaedic 
department for assessment of painless swelling of his 
knee causing him to have an emergency department 
visit. They visited regularly for joint assessment. And 
their nutritional and psychosocial status remained 
optimum. 
Table 2: Comparison of Outcomes in LDP patients 







Bleeding Episodes, N 420 425 
Hospital admission, N Nil 01 
Emergency HTC Visits, N 0 0 
Joint Assessment 
Compliance  
14 (100%) 14 (100%) 
Inhibitors, N 0 0 











Since the declaration of COVID -19 pandemic and 
imposition of SOPs, the WFH recommends minimising 
hospital visits and postponing non-urgent and elective 
surgeries for haemophilia patients.4 The same 
guidelines were adopted by the HTC, Rawalpindi.   
The above radical changes could lead to patients 
losing contact with the HTC and thereby losing access 
to healthcare and medication. It was pertinent to keep 
in touch with patients that were part of the LDP 
project to assess their bleeding phenotype and ensure 
they had access to their weekly dosage and continued 
being part of this clinical trial. Considering the above 
factors, HTC encouraged its patients to keep in touch 
via telephone and video conferences. Through virtual 
visits, patients were able to get an appreciation for 
adhering to medication and exercise and discuss 
symptoms such as bleeding and pain. A drastic rise in 
telephone communication occurred during the Intra-
pandemic period and overall no change in visits was 
observed among the two time periods.  Telemedicine 
has proven to be a great solution to address such a 
global crisis.7,8,9,10 Patients can discuss bleeding 
number and location, amount of factor concentrates 
administered, the type of physical activity they are 
engaged in, and were motivated to continue adhering 
to treatment.7 
The HTC offered its patients at-home dispensing of 
medication so they didn’t have to visit the Centre 
frequently, thereby minimising the risk of being 
infected with the COVID-19.11 The difference in overall 
consumption of factor concentrates among the two 
time periods was mild. None of the patients lost access 
to medication. The LDP patients continued taking their 
weekly dosage without any delay and none developed 
inhibitors. No significant difference in bleeding 
episodes was observed between the two time periods. 
The haemophilia patients are physically less active 
than the normal population because of fear of bleeding 
and already established arthropathy. The COVID-19 
pandemic and associated social distancing could 
further increase such confinement and cause 
worsening of quality of life.12 Home exercise programs 
have been shown to be equally effective.12 The HTC 
encouraged its patients to remain active even if they 
could not go out for walking, cycling or jogging. 
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Through telemedicine, patients were assessed 
regularly and recommended modified exercise 
programs, frequency of practice and intensity 
accordingly. All haemophilia patients that were part of 
the LDP project remained physically active. 
The COVID-19 pandemic has caused an increase in 
anxiety and depression among the general population 
due to social isolation, fears of infection, loss of work 
and changes in routine13. Fear of lack of access to 
health care, medication and home help, and 
continuing clinical trials are additional stressors faced 
by the haemophilia patients.14 The HTC, Rawalpindi 
motivated its patients to stay in touch with family and 
friends, continue performing daylight activities, use 
bed only for sleep and maintain a regular sleep-wake 
schedule. Full emotional support was provided to the 
LDP patients throughout the pandemic. Therefore, 
their psychosocial health remained optimum. 
Musculoskeletal disorders can cause chronic pain 
among haemophilia patients leading to significant 
suffering and worsening of quality of life.15 Through 
telemedicine, patients were able to contact the HTC 
well in time for pain management. Among the LDP 
patients, joint health remained optimum. 
Increased body weight, reduced sun exposure and 
mood disorders, all are side effects of confinement at 
home.14 The HTC recommended its patients to remain 
active and eat a balanced diet. They were encouraged 
to continue taking their weekly vitamin D 
supplementation to benefit bone mineral density and 
for protection against respiratory infections.14,16,17 The 
nutritional status of LDP patients remained optimum 
throughout the pandemic. 
Although social distancing and confinement is a smart 
strategy to restrict the spread of the COVID-19 
pandemic, it could affect the lives of the population 
(especially those already suffering from additional 
stressors), much more than the COVID-19 infection 
itself. However, timely anticipation and modified 
strategies to overcome such stressors can make the 
working of a healthcare centre successful.  
 
Conclusion 
Our study shows that timely anticipation of the 
potential impact of a pandemic and prompt 
development of modified mechanisms can indeed 
make the working of a Health Care Centre successful 
and prevent side effects on the lives of its patients. 
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